Litigation Details for Duke University v. Sandoz Inc. (D. Colo. 2018)
✉ Email this page to a colleague
Duke University v. Sandoz Inc. (D. Colo. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-04-26 |
| Court | District Court, D. Colorado | Date Terminated | 2023-05-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Raymond Paul Moore |
| Jury Demand | None | Referred To | Kristen L. Mix |
| Patents | 7,388,029; 9,579,270 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Duke University v. Sandoz Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Duke University v. Sandoz Inc. (D. Colo. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-09-18 | 111 | Order | obtained U.S. Patent Nos. 7,388,029 (“the ‘029 patent”) – the predecessor to the ‘270 Patent at issue here…‘819 patent is known as “bimatoprost.” The ‘819 patent did not make any 3 The patents seem … (“Duke”) is the owner of U.S. Patent No. 9,579,270 (“the ‘270 Patent”), covering “Methods for Treating…by filing previous patent infringement lawsuits, and another of which alleges patent misuse.2 …bifurcate Sandoz’s antitrust and patent misuse counterclaims from the patent infringement claims to stay | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
